These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 7578169

  • 1. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
    Gray J, Wreghitt TG, Pavel P, Smyth RL, Parameshwar J, Stewart S, Cary N, Large S, Wallwork J.
    J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus in pediatric patients after renal transplantation.
    Schwab M, Böswald M, Korn K, Ruder H.
    Clin Nephrol; 2000 Feb; 53(2):132-9. PubMed ID: 10711415
    [Abstract] [Full Text] [Related]

  • 3. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E, van der Bij W, de Boer W, Timens W, Middeldorp J, The TH.
    J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
    [Abstract] [Full Text] [Related]

  • 4. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [Abstract] [Full Text] [Related]

  • 5. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC, Paya CV, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, Daly RC, McGregor CG.
    J Heart Lung Transplant; 1995 Nov; 14(2):214-21. PubMed ID: 7779838
    [Abstract] [Full Text] [Related]

  • 6. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 7. A study of Epstein-Barr virus infections in heart and heart and lung transplant recipients.
    Wreghitt TG, Sargaison M, Sutehall G, Woodward CG, Scott J, English TA, Wallwork J.
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2502-3. PubMed ID: 2539676
    [No Abstract] [Full Text] [Related]

  • 8. [Epstein-Barr virus infection in patients after bone marrow and heart transplantation].
    Zawilińska B, Gruszka K, Piatkowska-Jakubas B, Garlicki M, Skotnicki A.
    Przegl Epidemiol; 2001 Feb; 55 Suppl 3():52-5. PubMed ID: 11984959
    [Abstract] [Full Text] [Related]

  • 9. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P, Buda A, Livi U, Rigotti P, Zanus G, Calabrese F, Caforio A, Menin C, Canova D, Farinati F, Luciana Aversa SM.
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO, Ni J, Denfield SW, Gajarski RJ, Radovancevic B, Frazier HO, Demmler GJ, Kearney D, Bricker JT, Towbin JA.
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [Abstract] [Full Text] [Related]

  • 11. [Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)].
    Seigneurin JM, Kressmann MC, Lavoué MF, Saez G, Lenoir G.
    Nouv Presse Med; 1978 Dec 09; 7(44):4005-10. PubMed ID: 215969
    [Abstract] [Full Text] [Related]

  • 12. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N.
    Srp Arh Celok Lek; 1998 Dec 09; 126(3-4):97-100. PubMed ID: 9863363
    [Abstract] [Full Text] [Related]

  • 13. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
    Babel N, Gabdrakhmanova L, Hammer M, Rosenberger C, Oppert M, Volk HD, Reinke P.
    Transpl Infect Dis; 2005 Dec 09; 7(3-4):133-6. PubMed ID: 16390402
    [Abstract] [Full Text] [Related]

  • 14. Quantification of Epstein-Barr virus-DNA load in lung transplant recipients: a comparison of plasma versus whole blood.
    Bakker NA, Verschuuren EA, Veeger NJ, van der Bij W, van Imhoff GW, Kallenberg CG, Hepkema BG.
    J Heart Lung Transplant; 2008 Jan 09; 27(1):7-10. PubMed ID: 18187080
    [Abstract] [Full Text] [Related]

  • 15. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.
    Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS.
    J Heart Lung Transplant; 1991 Jan 09; 10(6):877-86; discussion 886-7. PubMed ID: 1661607
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr viral infection in renal allograft recipients: a single center experience.
    Zadeh ZR, Makhdumi K, Lak SS.
    Saudi J Kidney Dis Transpl; 2006 Sep 09; 17(3):351-4. PubMed ID: 16970255
    [Abstract] [Full Text] [Related]

  • 17. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H, Qorashi M, Heidari A.
    Transplant Proc; 2009 Sep 09; 41(7):2761-3. PubMed ID: 19765428
    [Abstract] [Full Text] [Related]

  • 18. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 09; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 19. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.
    Benden C, Aurora P, Burch M, Cubitt D, Lloyd C, Whitmore P, Neligan SL, Elliott MJ.
    J Heart Lung Transplant; 2005 Dec 09; 24(12):2103-8. PubMed ID: 16364857
    [Abstract] [Full Text] [Related]

  • 20. Incidence of reactive antibodies against epstein-barr in a group of renal transplant patients.
    Geramizadeh B, Aghdai M, Azarpira N, Behabahani AB, Heidari T, Banihashemi M, Raisjalali AR, Roozbeh J, Behzadi A.
    Transplant Proc; 2005 Sep 09; 37(7):3051-2. PubMed ID: 16213301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.